![]() |
인쇄하기
취소
|
Health insurance ceiling prices of 80 registered pharmaceutical products, such as Mabthera Inj, a target agent, will be reduced from the 1st of the next month.
The reduced price of Baraclude, a chronic hepatitis B treatment expired in substance patent soon, will be applied from the 10th.
Moreover, 223 products, such as Tysabri Inj, a multiple arteriosclerosis treatment, will be newly register...